Pages that link to "Q40055464"

The following pages link to Temporal Effects of Drug and Placebo in Delaying Relapse in Schizophrenic Outpatients (Q40055464):

Displaying 36 items.

• Supportive therapy for schizophrenia (Q24186517) (← links)
• Social skills programmes for schizophrenia (Q24187223) (← links)
• Maintenance treatment with antipsychotic drugs for schizophrenia (Q24197902) (← links)
• Chlorpromazine versus placebo for schizophrenia (Q24201214) (← links)
• Olanzapine depot for schizophrenia (Q24240925) (← links)
• Supportive therapy for schizophrenia (Q24243152) (← links)
• Supportive therapy for schizophrenia (Q24244072) (← links)
• Chlorpromazine versus placebo for schizophrenia (Q24245181) (← links)
• Cessation of medication for people with schizophrenia already stable on chlorpromazine (Q24246474) (← links)
• Chlorpromazine versus placebo for schizophrenia (Q24248704) (← links)
• Family psychoeducation and schizophrenia: a review of the literature (Q28202186) (← links)
• Perceptions of efficacy, expressed emotion, and the course of schizophrenia: the case of emotional overinvolvement (Q34204319) (← links)
• The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal. (Q34418847) (← links)
• Depot antipsychotic drugs. Place in therapy (Q34719546) (← links)
• Pharmacologic features and effects of neuroleptics (Q35776516) (← links)
• Adverse effects in maintenance treatment: Practical and theoretical considerations (Q39310382) (← links)
• Survival analysis (or time to an event analysis), and the Cox regression model--methods for longitudinal psychiatric research (Q39760068) (← links)
• The Rehabilitation of Psychiatric Patients* (Q40144820) (← links)
• Low dose maintenance medication for schizophrenia. (Q41886551) (← links)
• Partial compliance with antipsychotic medication is common in patients with schizophrenia (Q45141137) (← links)
• Tardive dyskinesia and informed consent (Q46327667) (← links)
• Opportunities and challenges presented by the new generation antipsychotics (Q47596300) (← links)
• The Black Book of Psychotropic Dosing and Monitoring (Q47642128) (← links)
• Partnering with families: multiple family group psychoeducation for schizophrenia (Q51867554) (← links)
• Plasma levels of fluphenazine and prolactin in psychiatric patients. (Q52069232) (← links)
• The problem-solving support group: structured group therapy with psychiatric inpatients. (Q52082458) (← links)
• A scale for detection of negative attitudes towards medication among relatives of schizophrenic patients. (Q52090015) (← links)
• Clinical rating of compliance in chronic hemodialysis patients. (Q52913436) (← links)
• The neuropsychology of schizophrenia: A perspective from neurobehavioral genetics (Q56896418) (← links)
• Why don't preschizophrenic children have delusions and hallucinations? (Q57403541) (← links)
• Excitatory amino acids, NMDA and sigma receptors: A role in schizophrenia? (Q60513754) (← links)
• The limbic-striatal interaction: A seesaw rather than a tandem (Q63866035) (← links)
• Family understanding of psychiatric illness (Q69695748) (← links)
• Tardive dyskinesia (Q71556528) (← links)
• Long-term neuroleptic treatment of chronic schizophrenic patients: Clinical and biochemical effects of withdrawal (Q72472915) (← links)
• The limitations of antipsychotic medication on schizophrenia relapse and adjustment and the contributions of psychosocial treatment (Q77482076) (← links)